Valério-Bolas Ana, Meunier Mafalda, Palma-Marques Joana, Rodrigues Armanda, Santos Ana Margarida, Nunes Telmo, Ferreira Rui, Armada Ana, Alves João Carlos, Antunes Wilson, Cardoso Inês, Mesquita-Gabriel Sofia, Lobo Lis, Alexandre-Pires Graça, Marques Luís, Pereira da Fonseca Isabel, Santos-Gomes Gabriela
Global Health and Tropical Medicine (GHTM), Associate Laboratory in Translation and Innovation towards Global Health, LA-REAL, Instituto de Higiene e Medicina Tropical (IHMT), Universidade NOVA de Lisboa (UNL), 1349-008 Lisbon, Portugal.
Divisão de Medicina Veterinária, Guarda Nacional Republicana, 1200-771 Lisbon, Portugal.
Cells. 2024 Mar 3;13(5):445. doi: 10.3390/cells13050445.
Dendritic cells (DCs) capture pathogens and process antigens, playing a crucial role in activating naïve T cells, bridging the gap between innate and acquired immunity. However, little is known about DC activation when facing parasites. Thus, this study investigates in vitro activity of canine peripheral blood-derived DCs (moDCs) exposed to and parasites and their extracellular vesicles (EVs). increased toll-like receptor 4 gene expression in synergy with nuclear factor κB activation and the generation of pro-inflammatory cytokines. This parasite also induced the expression of class II molecules of major histocompatibility complex (MHC) and upregulated co-stimulatory molecule CD86, which, together with the release of chemokine CXCL16, can attract and help in T lymphocyte activation. In contrast, induced moDCs to generate a mix of pro- and anti-inflammatory cytokines, indicating that this parasite can establish a different immune relationship with DCs. EVs promoted moDCs to express class I MHC associated with the upregulation of co-stimulatory molecules and the release of CXCL16, suggesting that EVs can modulate moDCs to attract cytotoxic CD8 T cells. Thus, these parasites and their EVs can shape DC activation. A detailed understanding of DC activation may open new avenues for the development of advanced leishmaniasis control strategies.
Front Cell Infect Microbiol. 2020
Int J Mol Sci. 2025-2-18
J Nanobiotechnology. 2024-11-28
Immunology. 2021-11
Front Immunol. 2019-2-22